Medical Journals

Differential Hypertrophic Effects of Cardiotrophin-1 on Adult Cardiomyocytes from Normotensive and Spontaneously Hypertensive Rats.

Authors:
  • López Natalia
  • Díez Javier
  • Fortuño María Antonia

From: Division of Cardiovascular Sciences, Centre for Applied Medical Research (CIMA), Avda. Pio XII, 55. 31008, University of Navarra, Pamplona, Spain.

Journal of molecular and cellular cardiology

  • Publish Date: Nov 2006
  • ISSN: 0022-2828
  • Volume: 41
  • Issue: 5
  • Pages: 902-13
  • Medium: Print
  • Language: English
  • Citation (JAMA): López Natalia, Díez Javier, Fortuño María Antonia, et al. Differential Hypertrophic Effects of Cardiotrophin-1 on Adult Cardiomyocytes from Normotensive and Spontaneously Hypertensive Rats.. J. Mol. Cell. Cardiol. Nov 2006;41:902-13

Abstract

Cardiotrophin-1 (CT-1) produces longitudinal elongation of neonatal cardiomyocytes, but its effects in adult cardiomyocytes are not known. Recent observations indicate that CT-1 may be involved in pressure overload left ventricular hypertrophy (LVH). We investigated whether the hypertrophic effects of CT-1 are different in cardiomyocytes isolated from adult normotensive and spontaneously hypertensive rats (SHR). Hypertrophy was evaluated by planimetry and confocal microscopy, contractile proteins were quantified by Western blotting and real-time RT-PCR, and intracellular pathways were analyzed with specific chemical inhibitors. CT-1 increased c-fos and ANP expression (p<0.01) and cell area (p<0.01) in cardiomyocytes from both rat strains. In Wistar cells, CT-1 augmented cell length (p<0.01) but did not modify either the transverse diameter or cell depth. In SHR cells, CT-1 increased cell length (p<0.05), cell width (p<0.01) and cell depth, augmented the expression of myosin light chain-2v (MLC-2v) and skeletal alpha-actin (p<0.01) and enhanced MLC-2v phosphorylation (p<0.01). The blockade of gp130 or LIFR abolished CT-1-induced growth in the two cell types. All distinct effects observed in cardiomyocytes from SHR were mediated by STAT3. Baseline angiotensinogen expression was higher in SHR cells, and CT-1 induced a 1.7-fold and 3.2-fold increase of angiotensinogen mRNA in cardiomyocytes from Wistar rats and SHR respectively. In addition, AT1 blockade inhibited the specific effects of CT-1 in SHR cells. Finally, ex vivo determinations revealed that adult SHR exhibited enhanced myocardial CT-1 (mRNA and protein, p<0.01), increased cell width (p<0.01) and concentric LVH compared with pre-hypertensive SHR. These findings reveal a specific cell-broadening effect of CT-1 in cardiomyocytes from adult SHR and suggest that the hypertensive phenotype of these cells may influence the hypertrophic effects of CT-1, probably by means of an exaggerated induction of angiotensinogen expression. We suggest that CT-1 might facilitate LVH in genetic hypertension through a cross-talk with the renin-angiotensin system.

Mesh Headings (Keywords): Animals, Cells, Cultured, Contractile Proteins, Cytokines, Hypertension, Hypertrophy, Left Ventricular, Myocardium, Myocytes, Cardiac, Rats, Rats, Inbred BB, Rats, Inbred SHR, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 17014864


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.